Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell

The Journal of Clinical Investigation
A LeriP Anversa

Abstract

Physical forces activate apoptosis and gene expression, but the mechanism is unknown. For this purpose, adult myocytes were stretched in an equibiaxial stretch apparatus and the magnitude of cell death was examined 4 and 24 h later. The possibility of stretch-mediated activation of p53 and p53-dependent genes was evaluated at 30 min, 2, 4, 8, and 24 h. Myocyte apoptosis increased by 4.4- and 7.6-fold at 4 and 24 h after stretch. p53 binding to the promoter of angiotensinogen, AT1 receptor, and Bax also increased. Expression of angiotensinogen, AT1 receptor, p53, and Bax increased and Bcl-2 decreased in stretched myocytes. The changes in AT1 receptor, p53, Bax, and Bcl-2 became more apparent with the duration of stretch. Angiotensin II concentration in the medium increased at 10 min, reaching maximal levels at 1 and 20 h. The AT1 blocker, losartan, abolished apoptosis in stretched myocytes. Myocyte volume was not influenced by stretch. In conclusion, stretch-mediated release of angiotensin II is coupled with apoptosis and the activation of p53 which may be responsible for the prolonged upregulation of the local renin-angiotensin system and the increased susceptibility of myocytes to undergo apoptosis.

References

Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J SadoshimaS Izumo
Jan 1, 1992·Annual Review of Physiology·K M BakerD E Dostal
Jul 14, 1988·The New England Journal of Medicine·M A PfefferE Braunwald
Jul 1, 1988·Circulation·H F WeismanB Healy
Dec 1, 1972·Journal of Molecular and Cellular Cardiology·L Vitali-MazzaO Visioli
Jul 1, 1980·Circulation Research·S WallensteinJ L Fleiss
Jan 1, 1994·Cold Spring Harbor Symposia on Quantitative Biology·T R Hupp, D P Lane
Nov 1, 1995·The Journal of Clinical Investigation·W ChengP Anversa
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·P AtadjaK Riabowol
Jun 6, 1995·Biochemical and Biophysical Research Communications·K G ShyuC C Liew
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·D PennicaK R Chien
Oct 21, 1994·Cell·Z N Oltvai, S J Korsmeyer
Oct 1, 1995·Trends in Biochemical Sciences·O B ChernovaG R Stark
Aug 15, 1996·The New England Journal of Medicine·J N Cohn
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·K ReissP Anversa
Aug 1, 1996·Experimental Cell Research·W ChengP Anversa
Oct 17, 1996·The New England Journal of Medicine·J NarulaB A Khaw
Oct 17, 1996·The New England Journal of Medicine·Z MallatG Fontaine
Oct 17, 1996·The New England Journal of Medicine·W S Colucci
Mar 15, 1997·Experimental Cell Research·E CigolaP Anversa
Apr 17, 1997·The New England Journal of Medicine·G OlivettiP Anversa
Mar 1, 1997·Journal of Molecular and Cellular Cardiology·J KajsturaP Anversa
Jul 10, 1997·Experimental Cell Research·P PierzchalskiP Anversa

❮ Previous
Next ❯

Citations

Jan 9, 2001·Journal of Cellular Physiology·K HasegawaS Sasayama
Dec 16, 1998·Clinical Cardiology·K KurrelmeyerD L Mann
Dec 31, 2002·Journal of Molecular and Cellular Cardiology·Noeleen De AngelisSerge Masson
Aug 9, 2001·Irish Journal of Medical Science·R McLaughlinD Bouchier-Hayes
May 6, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Christian WernerMichael Böhm
Feb 9, 2011·Pflügers Archiv : European journal of physiology·Horacio E CingolaniNéstor G Pérez
Oct 11, 2005·Apoptosis : an International Journal on Programmed Cell Death·B E WildhaberD H Teitelbaum
May 11, 2005·Cardiovascular Drugs and Therapy·Pasquale Pagliaro, Claudia Penna
Apr 2, 2003·Current Atherosclerosis Reports·Briain D MacNeillRoger J Hajjar
Jan 27, 2007·Current Diabetes Reports·Zhenqi Liu
Sep 12, 2000·Current Hypertension Reports·E L Schiffrin
Oct 3, 2003·Biochemical and Biophysical Research Communications·Xu Dong LiaoShi Qiang Wang
Jul 13, 2005·Progress in Biophysics and Molecular Biology·Shant Der SarkissianMohan K Raizada
Apr 20, 2005·Regulatory Peptides·Horacio E CingolaniMaría C Camilión de Hurtado
Nov 6, 2001·The American Journal of Cardiology·V J DzauUNKNOWN Working Group on Tissue Angiotensin-converting enzyme, International Society of Cardiovascular Pharmacotherapy
Jun 12, 2003·European Journal of Pharmacology·Miklos VecsernyesArpad Tosaki
May 10, 2003·Journal of Molecular and Cellular Cardiology·Sumanth D PrabhuBysani Chandrasekar
Nov 14, 2002·Progress in Biophysics and Molecular Biology·Florian Wernig, Qingbo Xu
Jul 8, 1999·Regulatory Peptides·M de Gasparo, H M Siragy
Jul 8, 1999·Regulatory Peptides·L J MillattH M Siragy
Feb 25, 2000·Molecular and Cellular Endocrinology·B S Noble, J Reeve
Jun 19, 2001·Experimental Gerontology·M Mayr, Q Xu
Feb 11, 2003·Journal of the American College of Cardiology·Jun SuzukiWilbur Y W Lew
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·A H Jan Danser
Apr 1, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Andrea FrustaciMatteo A Russo
Aug 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Peter M AbadirJeremy D Walston
Jan 17, 2012·Clinical and Experimental Pharmacology & Physiology·Jing HuangHui Wang
May 2, 2000·Journal of Cardiac Surgery·R García-RinaldiD H Glaeser
Apr 9, 2010·Science Translational Medicine·Saptarsi M HaldarMukesh K Jain
Jan 12, 2008·Annual Review of Medicine·David M KayeKenneth R Chien
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Michael Bader

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis